Published in Int Urogynecol J Pelvic Floor Dysfunct on June 23, 2004
Incisionless per vaginal bone anchor cystourethropexy for the treatment of female stress incontinence: experience with the first 50 patients. J Urol (1997) 1.07
An in-line suturing device to simplify sacrospinous vaginal vault suspension. Obstet Gynecol (1997) 0.94
Comparison of biomechanical properties of periosteal suture fixation and bone anchor fixation to the pubic bone. Urology (2000) 0.84
Sacrospinous Ligament Fixation Simplified with a New Endoscopic Suturing Device J Am Assoc Gynecol Laparosc (1996) 0.84
Transvaginal therapy of genuine stress incontinence. Urology (2000) 0.84
Comparison of anchors used in anti-incontinence surgery. Urology (1998) 0.84
Vesica percutaneous bladder neck stabilization. J Endourol (1996) 0.84
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J (2009) 7.12
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn (2010) 5.48
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc (2003) 2.75
Foreign-body granuloma after injection of calcium hydroxylapatite for type III stress urinary incontinence. Obstet Gynecol (2011) 1.75
Botulinum toxin A in the overactive bladder: current status and future directions. BJU Int (2007) 1.69
Two unusual presentations of bladder diverticula. Obstet Gynecol (2011) 1.67
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology (2003) 1.62
The use of intraoperative cystoscopy in major vaginal and urogynecologic surgeries. Am J Obstet Gynecol (2002) 1.56
Incidence of pubic osteomyelitis after bladder neck suspension using bone anchors. Urology (2004) 1.56
Can pelvic floor injury secondary to delivery be prevented? Int Urogynecol J (2011) 1.46
Histologic characterization of vaginal vs. abdominal surgical wound healing in a rabbit model. Wound Repair Regen (2007) 1.39
Predicting urinary tract infections in a urogynecology population. Urol Nurs (2008) 1.38
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol (2007) 1.27
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT). Clin Ther (2006) 1.23
Perceptions and behaviours of women with bladder control problems. Fam Pract (2006) 1.22
Predicting treatment choice for patients with pelvic organ prolapse. Obstet Gynecol (2003) 1.17
Delivery mode is a major environmental determinant of stress urinary incontinence: results of the Evanston-Northwestern Twin Sisters Study. Am J Obstet Gynecol (2005) 1.16
Is transobturator tape as effective as tension-free vaginal tape in patients with borderline maximum urethral closure pressure? Am J Obstet Gynecol (2006) 1.14
Detrusor overactivity and urge urinary incontinence following trans obturator versus midurethral slings. Neurourol Urodyn (2007) 1.11
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol (2009) 1.11
Extrasphincteric perianal fistulae after sacrospinous fixation for apical prolapse. Obstet Gynecol (2011) 1.08
Risk factors for female anal incontinence: new insight through the Evanston-Northwestern twin sisters study. Obstet Gynecol (2005) 1.08
A prospective randomized trial using solvent dehydrated fascia lata for the prevention of recurrent anterior vaginal wall prolapse. Am J Obstet Gynecol (2005) 1.07
Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am J Obstet Gynecol (2008) 1.07
Effect of parity on sexual function: an identical twin study. Obstet Gynecol (2006) 1.07
Diagnosis of interstitial cystitis/ painful bladder syndrome in patients with overactive bladder symptoms. Rev Urol (2007) 1.02
Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology (2006) 1.01
Is pelvic organ prolapse a cause of pelvic or low back pain? Obstet Gynecol (2002) 0.99
Histopathologic changes of porcine dermis xenografts for transvaginal suburethral slings. Am J Obstet Gynecol (2005) 0.97
Site-specific rectocele repair compared with standard posterior colporrhaphy. Obstet Gynecol (2005) 0.96
Nocturia: etiology, diagnosis, and treatment. Neurourol Urodyn (2008) 0.93
Urinary incontinence among mothers of multiples: the protective effect of cesarean delivery. Am J Obstet Gynecol (2003) 0.92
Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.91
Impact of hysterectomy on stress urinary incontinence: an identical twin study. Am J Obstet Gynecol (2008) 0.90
Extended-release trospium chloride improves quality of life in overactive bladder. Value Health (2009) 0.90
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study. Urology (2008) 0.89
Sacrohysteropexy followed by successful pregnancy and eventual reoperation for prolapse. Int Urogynecol J (2011) 0.89
Do alterations in vaginal dimensions after reconstructive pelvic surgeries affect the risk for dyspareunia? Am J Obstet Gynecol (2005) 0.89
Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. Urology (2008) 0.88
Arcus-anchored acellular dermal graft compared to anterior colporrhaphy for stage II cystoceles and beyond. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.86
TVT versus SPARC: comparison of outcomes for two midurethral tape procedures. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.85
Pathophysiology of the overactive bladder. Clin Obstet Gynecol (2002) 0.85
Measuring the success of combined intravesical dimethyl sulfoxide and triamcinolone for treatment of bladder pain syndrome/interstitial cystitis. Int Urogynecol J (2012) 0.84
Prevalence of anal incontinence among mothers of multiples and analysis of risk factors. Am J Obstet Gynecol (2003) 0.84
The PISQ-IR: considerations in scale scoring and development. Int Urogynecol J (2013) 0.84
A Valid Form of the PISQ-12, the PISQ-9, for Use in Comparative Studies of Women With and Without Pelvic Organ Prolapse and/or Urinary Incontinence. Female Pelvic Med Reconstr Surg (2010) 0.83
Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement? BJU Int (2010) 0.83
Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns--positive reactions are possible. Int Urogynecol J (2011) 0.83
Urethral sphincter morphology in women with detrusor instability. Obstet Gynecol (2002) 0.83
Effect of bilateral oophorectomy on wound healing of the rabbit vagina. Fertil Steril (2010) 0.83
Detrusor overactivity and urge urinary incontinence [corrected] following midurethral versus bladder sling procedures. Am J Obstet Gynecol (2005) 0.83
The development of pelvic organ prolapse following isolated Burch retropubic urethropexy. Int Urogynecol J Pelvic Floor Dysfunct (2003) 0.82
Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. Am J Obstet Gynecol (2005) 0.82
Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference. Clin Drug Investig (2011) 0.81
Expression of platelet-derived growth factor-B mRNA during vaginal vs. dermal incisional wound healing in the rabbit. Eur J Obstet Gynecol Reprod Biol (2012) 0.81
Urge incontinence: estimating environmental and obstetrical risk factors using an identical twin study. Int Urogynecol J (2010) 0.81
Management of incontinence for family practice physicians. Am J Med (2006) 0.81
A randomized controlled trial comparing a modified Burch procedure and a suburethral sling: long-term follow-up. Int Urogynecol J Pelvic Floor Dysfunct (2003) 0.80
Diagnosis and treatment of interstitial cystitis/painful bladder syndrome: a review. J Womens Health (Larchmt) (2010) 0.80
Enhanced interpretability of the PFDI-20 with establishment of reference scores among women in the general population. Neurourol Urodyn (2012) 0.80
Preoperative Valsalva voiding increases the risk of urinary retention after midurethral sling placement. Int Urogynecol J (2010) 0.79
The effect of preemptive pudendal nerve blockade on pain after transvaginal pelvic reconstructive surgery. Obstet Gynecol (2005) 0.79
Eosinophilic cystitis after bladder instillation with dimethyl sulfoxide. Urology (2004) 0.79
Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study. Pharmacoeconomics (2009) 0.79
Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study. Neurourol Urodyn (2013) 0.79
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials. Int Urol Nephrol (2007) 0.79
Chronic pelvic actinomycosis following a bone anchored sling procedure. J Urol (2004) 0.79
Successful treatment of Zoon's vulvitis with high potency topical steroid. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.78
Treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitis. Am J Obstet Gynecol (2008) 0.78
Biomechanical characterization of vaginal versus abdominal surgical wound healing in the rabbit. Am J Obstet Gynecol (2006) 0.78
Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms. Curr Med Res Opin (2011) 0.77
InTone: a novel pelvic floor rehabilitation device for urinary incontinence. Int Urogynecol J (2014) 0.77
Prospective cohort study of bowel function after robotic sacrocolpopexy. Female Pelvic Med Reconstr Surg (2014) 0.76
Factors influencing the long-term success of periurethral collagen therapy in the office. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.76
Oxybutynin: past, present, and future. Int Urogynecol J (2012) 0.76
Vulvodynia & pelvic pain? Think interstitial cystitis. Nurse Pract (2008) 0.76
Nongenetic factors associated with stress urinary incontinence. Obstet Gynecol (2011) 0.76
Editorial comment on "An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction". Int Urogynecol J (2009) 0.75
A prospective study of a single-incision sling at the time of robotic sacrocolpopexy. Int Urogynecol J (2014) 0.75
The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients. Dis Mon (2013) 0.75
Editorial comment on "An International Urogynecological Association (IUGA)/International continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction". Neurourol Urodyn (2010) 0.75
Reply by authors: "Technique of urethral retro-resistance pressure measurement". Neurourol Urodyn (2005) 0.75
Cystoscopy for lower urinary tract symptoms in urogynecologic practice: the likelihood of finding bladder cancer. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.75
Extracorporeal electromagnetic stimulation for urinary incontinence and bladder disease. Adv Exp Med Biol (2003) 0.75
Subjective measures of efficacy and quality of life in overactive bladder syndrome. Curr Urol Rep (2008) 0.75
Conservative therapy for overactive bladder: pelvic floor exercises. Curr Urol Rep (2002) 0.75